Поиск по каталогу |
(строгое соответствие)
|
- Профессиональная
- Научно-популярная
- Художественная
- Публицистика
- Детская
- Искусство
- Хобби, семья, дом
- Спорт
- Путеводители
- Блокноты, тетради, открытки
Multicentric Global Governance For Health. A Proposal For A New Approach To How We Govern Health
В наличии
Местонахождение: Алматы | Состояние экземпляра: новый |
Бумажная
версия
версия
Автор: Rachel Kiddell-Monroe
ISBN: 9783659542749
Год издания: 2014
Формат книги: 60×90/16 (145×215 мм)
Количество страниц: 124
Издательство: LAP LAMBERT Academic Publishing
Цена: 32741 тг
Положить в корзину
Способы доставки в город Алматы * комплектация (срок до отгрузки) не более 2 рабочих дней |
Самовывоз из города Алматы (пункты самовывоза партнёра CDEK) |
Курьерская доставка CDEK из города Москва |
Доставка Почтой России из города Москва |
Аннотация: Global health governance structures today are failing to address the global health crises of both communicable and non-communicable diseases. This failure is driven by the trend of a market justice approach to health and a lack of global health leadership. Kiddell-Monroe demonstrates how these trends impacted the negotiation of global intellectual property regulations and debates on access to NCD medicines in favour of private over public interest. She concludes that this trend raises three central challenges for global health: (i) addressing broad participation, (ii) the dilution of the meaning of global health, and (iii) the co-optation of the global health agenda by corporate interests. Using nodal and constitutional theory, Kiddell-Monroe proposes a multicentric global governance for health model that can directly address the trends and their global health related challenges. The multicentric model offers a framework in which WHO, States and non-State actors can collectively govern global health so as to truly promote equity and social justice.
Ключевые слова: development, Developing Countries, Health, governance, Africa, Human Rights, Law, intellectual property, Innovation, bioethics, non-state actors, International, Pharmaceutical Companies, states, global health, medical research, Conflict of Interest, Access to Medicines, World Health Organisation